Filing Flows › Electromed (ELMD) › Q4 FY26 › vs Q4 FY25
Electromed (ELMD) Q4 FY26 vs Q4 FY25 (year over year)
Electromed's revenue rose $2.0M (+12%) from $17.4M in Q4 FY25 to $19.4M in Q4 FY26. Gross margin 78.7% against 78.3% (+0.4 pts).
Electromed, Q4 FY26: revenue $19.4M (+12% year over year), operating margin 19.7%, net earnings $3.4M, operating cash flow $3.0M. The chart draws each line against Q4 FY25, the increases inside each band.
Margins
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Gross margin | 78.7% | 78.3% | +0.4 pts |
| Operating margin | 19.7% | 17.5% | +2.2 pts |
| Net margin | 17.5% | 12.7% | +4.8 pts |
| Free cash flow margin | 14.3% | 21.4% | -7.1 pts |
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $19.4M | $17.4M | $2.0M | +12% |
| Gross profit | $15.3M | $13.6M | $1.7M | +12% |
| Cost of revenue | $4.1M | $3.8M | $364K | +10% |
| Other income, net | $136K | $135K | $1K | +0.7% |
| Operating profit | $3.8M | $3.0M | $785K | +26% |
| Operating expenses | $11.5M | $10.6M | $875K | +8% |
| Pre-tax earnings | $4.0M | $3.2M | $786K | +25% |
| Research & development | $328K | $302K | $26K | +9% |
| SG&A | $11.1M | $10.3M | $849K | +8% |
| Net earnings | $3.4M | $2.2M | $1.2M | +54% |
| Income tax | $560K | $971K | −$411K | -42% |
| Depreciation & amortization | $122K | $397K | −$275K | -69% |
| Share-based compensation | $762K | $650K | $112K | +17% |
| Working capital & other | $1.3M | −$608K | $1.9M | — |
| Operating cash flow | $3.0M | $3.9M | −$865K | -22% |
| Free cash flow (OCF − capex) | $2.8M | $3.7M | −$939K | -25% |
| Capital expenditures | $219K | $145K | $74K | +51% |
Questions
How much did Electromed's revenue grow year over year in Q4 FY26?
Electromed's revenue rose $2.0M (+12%) from $17.4M in Q4 FY25 to $19.4M in Q4 FY26. Gross margin 78.7% against 78.3% (+0.4 pts).